Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

X4 Pharmaceuticals Submitted a Marketing Application To The FDA For The Approval Of Once-daily, Oral Mavorixafor For Individuals Aged 12 And Older With WHIM (Warts, Hypogammaglobulinemia, Infections, Myelokathexis) Syndrome, A Rare Immunodeficiency

Author: Benzinga Newsdesk | September 05, 2023 08:04am

Posted In: XFOR